American pharma company Viatris to sell certain businesses for $3.4bn
The drugmaker has received offer for its OTC business, and has agreed to divest its women's healthcare business,…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
03 Oct 23
The drugmaker has received offer for its OTC business, and has agreed to divest its women's healthcare business,…
03 Oct 23
GSK’s Jemperli plus chemotherapy is now approved for patients with a tumour abnormality called mismatch repair deficient /…
03 Oct 23
The approval was supported by the positive findings from the Phase 2 PHYOX 2 clinical trial and interim…
29 Sep 23
HitGen will leverage its DNA-encoded library (DEL) technology platform for the collaboration, specifically the OpenDEL solution, a self-service…
29 Sep 23
The FDA has cleared the muscle disorder therapy only for adult LOPD patients whose weight is ≥40kg and…
29 Sep 23
Scynexis has recalled the drug over potential risk of cross contamination with a non-antibacterial ß-lactam drug substance in…
29 Sep 23
The drug’s mechanism of targeted single serotonin (5HT) 1a receptor agonism reduced depressive symptoms with an acceptable side…
29 Sep 23
If approved, sotatercept would be the first in its class, bringing a novel approach to address a rare…
28 Sep 23
The FDA approval was supported by the data from the MIRA trial programme in which the percentage of…
28 Sep 23
ENTYVIO Is the Only FDA-Approved Ulcerative Colitis Biologic That Offers the Choice of Intravenous or Subcutaneous Maintenance Therapy